Valuation: Medistim ASA

Market Cap 4.74B 494M 441M 411M 374M 704M 47.61B 709M 4.96B 1.93B 24.3B 1.86B 1.82B 78.1B P/E 2026 *
25.9x
P/E 2027 * 23.9x
Enterprise Value 4.6B 480M 428M 399M 363M 684M 46.23B 689M 4.82B 1.88B 23.59B 1.8B 1.76B 75.84B EV / Sales 2026 *
5.76x
EV / Sales 2027 * 5.27x
Free-Float
79.47%
Yield 2026 *
3.33%
Yield 2027 * 3.46%
1 day+4.25%
1 week+7.14%
Current month+6.72%
1 month+8.43%
3 months+15.38%
6 months+27.36%
Current year+4.25%
1 week 250
Extreme 250
273
1 month 240
Extreme 240
273
Current year 186.5
Extreme 186.5
273
1 year 186.5
Extreme 186.5
292
3 years 130
Extreme 130
292
5 years 130
Extreme 130
402.5
10 years 60
Extreme 60
409
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2009
Director of Finance/CFO - 01/01/2001
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Chairman 78 01/01/2000
Director/Board Member 49 01/01/2014
Director/Board Member 56 01/04/2023
Date Insider Type Main position Quantity % Market Cap. Importance
3/4/25 A Buy

Chairman

860,735 4.6939%
1/27/25 A Buy

Chairman

45,000 0.2454%
1/9/25 A Buy

Chairman

30,000 0.1636%
Change 5-day change 1-year change 3-year change Capi.($)
+4.25%+7.14%+12.50%+28.57% 494M
+3.35%-0.27%+24.56%+35.89% 250B
+3.34%-2.69%+2.89%+2.00% 156B
+3.71%-2.00%-10.14%+40.12% 144B
-0.47%-3.88%-56.43%-17.96% 61.45B
+2.44%+0.46%+13.18%+20.82% 50.28B
+1.59%-1.53%-21.23%-19.77% 46.73B
+2.09%-2.24%+20.93%+55.22% 48.29B
+3.70%+1.25%-4.33%+40.74% 45.89B
+3.51%-0.64%+34.02%+65.46% 43.24B
Average +2.42%-1.77%+1.60%+25.11% 84.57B
Weighted average by Cap. +2.37%-2.77%+4.29%+25.37%

Financials

2026 *2027 *
Net sales 798M 83.31M 74.32M 69.24M 63.01M 119M 8.02B 120M 837M 326M 4.1B 313M 306M 13.16B 868M 90.62M 80.84M 75.31M 68.54M 129M 8.73B 130M 910M 354M 4.45B 340M 333M 14.32B
Net income 182M 19.04M 16.99M 15.83M 14.4M 27.12M 1.83B 27.32M 191M 74.4M 936M 71.48M 69.94M 3.01B 203M 21.18M 18.9M 17.6M 16.02M 30.17M 2.04B 30.39M 213M 82.76M 1.04B 79.51M 77.8M 3.35B
Net Debt -138M -14.35M -12.8M -11.92M -10.85M -20.43M -1.38B -20.59M -144M -56.05M -705M -53.86M -52.69M -2.27B -158M -16.54M -14.75M -13.74M -12.51M -23.56M -1.59B -23.73M -166M -64.62M -813M -62.08M -60.74M -2.61B
Logo Medistim ASA
Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Employees
159
Date Price Change Volume
06/10/26 NOK 270.00 +4.25% 86,477
05/10/26 NOK 259.00 +3.60% 24,613
02/10/26 NOK 250.00 -1.19% 11,420
01/10/26 NOK 253.00 0.00% 9,980
30/09/26 NOK 253.00 +0.40% 16,094
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
259.00NOK
Average target price
332.50NOK
Spread / Average Target
+28.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDI Stock